Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001415889-24-029964

PRESIDENT AND CEO sold 17,500 shares at an average $43.07 ($753,680)

  • PRESIDENT AND CEO acquired 75,161 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Option exercise 10b5-1 +3,772 $2.90 $10,927 89,714 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Sale 10b5-1 −3,772 $41.33 $155,883 85,942 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Option exercise 10b5-1 +2,195 $2.90 $6,358 88,137 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Sale 10b5-1 −2,195 $42.35 $92,949 85,942 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Option exercise 10b5-1 +5,023 $2.90 $14,551 90,965 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Sale 10b5-1 −5,023 $43.52 $218,609 85,942 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Option exercise 10b5-1 +4,635 $2.90 $13,427 90,577 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Sale 10b5-1 −4,635 $44.03 $204,094 85,942 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Option exercise 10b5-1 +1,875 $2.90 $5,432 87,817 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Sale 10b5-1 −1,875 $43.81 $82,144 85,942 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-19 Option exercise 10b5-1 +57,661 $2.90 $167,032 143,603 D
Derivatives
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,625 686,087 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-18 Option exercise · Stock Option (Right to Buy) 10b5-1 −1,875 684,212 D
Fordyce Marshall PRESIDENT AND CEO 2024-12-19 Option exercise · Stock Option (Right to Buy) 10b5-1 −57,661 626,551 D
Open-market sales · 17,500 sh · avg $43.07 · $753,680
Loading xslF345X05/form4-12202024_091238.xml…